INGNInogen, Inc.

$171M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$74M-6.3% YoY

Gross Profit

$34M46.0% margin

Operating Income

-$6M-7.5% margin

Net Income

-$5M-6.9% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$462M

Total Liabilities

$112M

Stockholders' Equity

$350M

Cash & Equivalents

$212M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$79M	-6.3%
Gross Profit	$34M	$34M	+0.4%
Operating Income	-$6M	-$5M	-3.8%
Net Income	-$5M	-$1M	-272.4%

Geographic Segments

UNITED STATES

$60M82%

Non Us

$14M18%

INGN Q4 2020 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena